More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons
CELLECTRA® 3PSP is designed to deliver INO-4800 directly into the skin, where the vaccine prompts the body's immune system to drive a robust immune response
A new survey finds 52 percent of individuals feel their symptoms are “ignored, dismissed, or not believed” when seeking medical treatment. That number rises to 6-in-10 within the Hispanic community.